Microbot Medical Inc.

Microbot Medical Inc.

MBOT·NASDAQ

$1.97

-0.51%
HealthcareMedical - Instruments & Supplies

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

At a Glance

Live Snapshot
Market Cap$89.77M
EPS-0.2900
P/E Ratio-6.79
Earnings Date08/11/2026

mbot

Capital Lease Obligations

Last Annual Value

569.00K

3-Year CAGR

47%

5-Year CAGR

-7%

10-Year CAGR

32%

Microbot Medical Inc.

Microbot Medical Inc. Competitors Analysis of Capital Lease Obligations

MBOT · NASDAQ
CompanyCapital Lease Obligations
CAGR 3Y
CAGR 5Y
CAGR 10Y
569.00K
35.1%-3.5%N/A 
DCGO logo
DocGo Inc.
NASDAQ:DCGO
28.94M
10.5%14.7%N/A
CLNN logo
Clene Inc.
NASDAQ:CLNN
3.25M
-16.1%-8.1%N/A
825.00K
10.6%N/AN/A
4.06M
-8.6%67.8%N/A
0.00
N/AN/AN/A
BTMD logo
biote Corp.
NASDAQ:BTMD
2.30M
4.9%43.7%N/A
0.00
N/AN/AN/A
LNSR logo
LENSAR, Inc.
NASDAQ:LNSR
2.73M
5.8%-3.8%N/A
939.00K
-37.4%-33.7%N/A
0.00
N/AN/AN/A
Microbot Medical Inc.

Microbot Medical Inc. Fair Value Envelope

MBOT · NASDAQ

Our analysis suggests that MBOT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.97, this represents a potential HIDDEN relative to our calculated worth for Microbot Medical Inc..

Intrinsic Value
Current Price: $1.97